 propafenon treatment symptomat paroxysm supraventricular arrhythmia random placebo-control crossov trial patient oral therapi object hypothesi propafenon prevent symptomat paroxysm supraventricular arrhythmia design open-label dose-find phase random double-blind placebo-control crossov phase treatment period day set outpati clinic patient thirty-thre patient paroxysm supraventricular tachycardia paroxysm atrial fibril arrhythmia electrocardiogram enrol twenty-thre patient paroxysm supraventricular tachycardia paroxysm atrial fibril data patient efficaci analysi intervent propafenon mg time patient mg patient mg patient placebo tablet random sequenc measur symptomat arrhythmia telephon transmiss electrocardiogram main result time first recurr overal group patient propafenon recurr rate arrhythmia treatment propafenon fifth recurr rate treatment placebo conclus propafenon effect symptomat paroxysm supraventricular arrhythmia